-Scroll.in A farmer describes her efforts to preserve 12 breeds of draught as well milch indigenous cattle. On Monday, the so-far peaceful protests against jallikattu on Chennai’s Marina Beach turned violent as the police sought to clear agitators from what had become ground zero of the movement against the Supreme Court ban on the bull-taming sport. Though an ordinance cleared on Saturday allowed the sport to take place this Pongal, the controversy...

-The Hindu Kalyanrao Jalji has cultivated carom seeds in drought-prone Chittapur taluk of Kalaburagi district Karnataka: When disturbing stories of agrarian crisis caused by drought were coming from across the State, Kalyanrao Jalji, a progressive farmer from Gotur village in drought-prone Chittapur taluk in Kalaburagi district, was making handsome profit. Cultivation of carom seeds (ajwain), a spice widely used in Indian kitchens for preparing delicacies as well as in pharmaceutical companies for...

-The Telegraph New Delhi: A health consortium today questioned a decision by Delhi High Court earlier this week to quash the Centre's ban on 344 cocktails of two or more medicines and urged doctors across the country to stop prescribing them. The Jan Swasthya Abhiyan (JSA), the Indian section of the global People's Health Movement, said it was shocked at the judgment because there was "no scientific rationale" for the continued use...

-The Hindu The proposal to extend the time limit for State-level drug regulatory approvals from four to 10 years could hit the generics market In a scathing letter to the Government of India, the Indian Pharmaceutical Alliance (IPA) took issue with what it considered to be a backdoor extension for data exclusivity norms in the country. It pointed to the recent government proposal to change the four-year time limit for State-level drug...

-The Times of India NEW DELHI: Prices of around 100 medicines, including those for Alzheimer's, diabetes and hypertension, could rise by up to 10% after they were removed from the national list of essential medicines. Though the move is likely to impact consumers, it comes as a relief to drug makers reeling under stringent price regulation for over a year. Overruling a previous order by the drug price regulator, the Centre has...